165 related articles for article (PubMed ID: 9438863)
61. The catalytic subunit of cAMP-dependent protein kinase: prototype for an extended network of communication.
Smith CM; Radzio-Andzelm E; Madhusudan ; Akamine P; Taylor SS
Prog Biophys Mol Biol; 1999; 71(3-4):313-41. PubMed ID: 10354702
[TBL] [Abstract][Full Text] [Related]
62. Molecular basis of AKAP specificity for PKA regulatory subunits.
Gold MG; Lygren B; Dokurno P; Hoshi N; McConnachie G; Taskén K; Carlson CR; Scott JD; Barford D
Mol Cell; 2006 Nov; 24(3):383-95. PubMed ID: 17081989
[TBL] [Abstract][Full Text] [Related]
63. (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition.
Dostmann WR
FEBS Lett; 1995 Nov; 375(3):231-4. PubMed ID: 7498506
[TBL] [Abstract][Full Text] [Related]
64. Dynamic binding of PKA regulatory subunit RI alpha.
Gullingsrud J; Kim C; Taylor SS; McCammon JA
Structure; 2006 Jan; 14(1):141-9. PubMed ID: 16407073
[TBL] [Abstract][Full Text] [Related]
65. Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase.
Glass DB; Trewhella J; Mitchell RD; Walsh DA
Protein Sci; 1995 Mar; 4(3):405-15. PubMed ID: 7795524
[TBL] [Abstract][Full Text] [Related]
66. Backbone flexibility of five sites on the catalytic subunit of cAMP-dependent protein kinase in the open and closed conformations.
Gangal M; Cox S; Lew J; Clifford T; Garrod SM; Aschbaher M; Taylor SS; Johnson DA
Biochemistry; 1998 Sep; 37(39):13728-35. PubMed ID: 9753461
[TBL] [Abstract][Full Text] [Related]
67. Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions.
Pflug A; Rogozina J; Lavogina D; Enkvist E; Uri A; Engh RA; Bossemeyer D
J Mol Biol; 2010 Oct; 403(1):66-77. PubMed ID: 20732331
[TBL] [Abstract][Full Text] [Related]
68. Definition of an electrostatic relay switch critical for the cAMP-dependent activation of protein kinase A as revealed by the D170A mutant of RIalpha.
Abu-Abed M; Das R; Wang L; Melacini G
Proteins; 2007 Oct; 69(1):112-24. PubMed ID: 17596845
[TBL] [Abstract][Full Text] [Related]
69. Effect of metal ions on high-affinity binding of pseudosubstrate inhibitors to PKA.
Zimmermann B; Schweinsberg S; Drewianka S; Herberg FW
Biochem J; 2008 Jul; 413(1):93-101. PubMed ID: 18373497
[TBL] [Abstract][Full Text] [Related]
70. Protein kinase inhibition of clinically important staurosporine analogues.
Gani OA; Engh RA
Nat Prod Rep; 2010 Apr; 27(4):489-98. PubMed ID: 20336234
[TBL] [Abstract][Full Text] [Related]
71. Binding-dependent disorder-order transition in PKI alpha: a fluorescence anisotropy study.
Hauer JA; Taylor SS; Johnson DA
Biochemistry; 1999 May; 38(21):6774-80. PubMed ID: 10346898
[TBL] [Abstract][Full Text] [Related]
72. [Mode of action of cyclic amp in prokaryotes and eukaryotes, CAP and cAMP-dependent protein kinases].
de Gunzburg J
Biochimie; 1985 Jun; 67(6):563-82. PubMed ID: 2413906
[TBL] [Abstract][Full Text] [Related]
73. Intrinsic relative preference profile of pan-kinase inhibitor drug staurosporine towards the clinically occurring gatekeeper mutations in Protein Tyrosine Kinases.
Ren Z; Li Q; Shen Y; Meng L
Comput Biol Chem; 2021 Oct; 94():107562. PubMed ID: 34428735
[TBL] [Abstract][Full Text] [Related]
74. Crystal structures of the catalytic subunit of cAMP-dependent protein kinase reveal general features of the protein kinase family.
Taylor SS; Radzio-Andzelm E; Knighton DR; Ten Eyck LF; Sowadski JM; Herberg FW; Yonemoto W; Zheng J
Receptor; 1993; 3(3):165-72. PubMed ID: 8167567
[TBL] [Abstract][Full Text] [Related]
75. Regulatory subunit of protein kinase A: structure of deletion mutant with cAMP binding domains.
Su Y; Dostmann WR; Herberg FW; Durick K; Xuong NH; Ten Eyck L; Taylor SS; Varughese KI
Science; 1995 Aug; 269(5225):807-13. PubMed ID: 7638597
[TBL] [Abstract][Full Text] [Related]
76. Crystallography for protein kinase drug design: PKA and SRC case studies.
Breitenlechner CB; Bossemeyer D; Engh RA
Biochim Biophys Acta; 2005 Dec; 1754(1-2):38-49. PubMed ID: 16269279
[TBL] [Abstract][Full Text] [Related]
77. Applying conformational selection theory to improve crossdocking efficiency in 3-phosphoinositide dependent protein kinase-1.
Kotasthane A; Mulakala C; Viswanadhan VN
Proteins; 2014 Mar; 82(3):436-51. PubMed ID: 23999908
[TBL] [Abstract][Full Text] [Related]
78. Bifunctional Ligands for Inhibition of Tight-Binding Protein-Protein Interactions.
Ivan T; Enkvist E; Viira B; Manoharan GB; Raidaru G; Pflug A; Alam KA; Zaccolo M; Engh RA; Uri A
Bioconjug Chem; 2016 Aug; 27(8):1900-10. PubMed ID: 27389935
[TBL] [Abstract][Full Text] [Related]
79. Dynamics of cAPK type IIbeta activation revealed by enhanced amide H/2H exchange mass spectrometry (DXMS).
Hamuro Y; Zawadzki KM; Kim JS; Stranz DD; Taylor SS; Woods VL
J Mol Biol; 2003 Apr; 327(5):1065-76. PubMed ID: 12662931
[TBL] [Abstract][Full Text] [Related]
80. Zooming in on protons: Neutron structure of protein kinase A trapped in a product complex.
Gerlits O; Weiss KL; Blakeley MP; Veglia G; Taylor SS; Kovalevsky A
Sci Adv; 2019 Mar; 5(3):eaav0482. PubMed ID: 30906862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
